We recently published a list of 12 Best Cosmetics Stocks to Buy for 2025. In this article, we are going to take a look at ...

Kenvue Inc. closed 4.37% below its 52-week high of $24.46, which the company achieved on November 26th.

The maker of Tylenol, a spinoff of J&J, has underperformed. But Kenvue could bounce back thanks to help from activist ...

Kenvue announced a five-year collaboration with Microsoft to transform digital operations through Artificial Intelligence (AI ...

Kenvue Inc., has announced a five-year collaboration with Microsoft which aims to transform digital operations through ...

That payout boost pushes the company's forward dividend yield up to 3.4%, more than double the S&P 500 's dividend yield of 1 ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on ...

Kenvue (KVUE) entered a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence ...

The collaboration aims to establish a strong foundation for transforming digital operations through advanced AI technologies.

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong ...